NEW YORK (AP) _ Rocket Pharmaceuticals Inc. (RCKT) on Thursday reported a loss of $19.9 million in its fourth quarter.

On a per-share basis, the New York-based company said it had a loss of 39 cents.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 56 cents per share.

For the year, the company reported that its loss widened to $77.3 million, or $1.58 per share.

Rocket Pharmaceuticals shares have dropped 13% since the beginning of the year. The stock has increased 12% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RCKT at https://www.zacks.com/ap/RCKT

Automated Insights, source Associated Press News